Steris (STE) FCF Payout Ratio Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -51.96% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9,472.45% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 2.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,472.45% |
| Dec 31, 2025 | -34.30% |
| Sep 30, 2025 | -18.67% |
| Jun 30, 2025 | -34.48% |
| Mar 31, 2025 | 227.17% |
| Dec 31, 2024 | -246.07% |
| Sep 30, 2024 | -53.77% |
| Jun 30, 2024 | 21.42% |
| Mar 31, 2024 | 4.14% |
| Dec 31, 2023 | -27.70% |
| Sep 30, 2023 | -63.34% |
| Jun 30, 2023 | -41.72% |
| Mar 31, 2023 | -316.08% |
| Dec 31, 2022 | 56.48% |
| Sep 30, 2022 | 390.05% |
| Jun 30, 2022 | -55.38% |
| Mar 31, 2022 | 1,289.31% |
| Dec 31, 2021 | 161.68% |
| Sep 30, 2021 | 57.67% |
| Jun 30, 2021 | 77.88% |
| Mar 31, 2021 | 104.81% |
| Dec 31, 2020 | -203.29% |
| Sep 30, 2020 | -5.93% |
| Jun 30, 2020 | -3.34% |
| Dec 31, 2019 | 162.86% |
| Sep 30, 2019 | -2.70% |
| Jun 30, 2019 | 34.64% |